Press release
The Dermatophytic Onychomycosis Therapeutics Market to Witness Escalation Backed By Gene Therapies
The Dermatophytic Onychomycosis Therapeutics Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes.The global dermatophytic onychomycosis therapeutics (DOT) market is anticipated to expand at a healthy CAGR of around 7% during the forecast period. The market is expected to be worth US$ 8.9 Bn by the end of this decade, increasing from US$ 4.6 Bn in 2021.
By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR during the forecast period.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/5840
By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for over 3/5 share of the total global dermatophytic onychomycosis market revenue by 2021.
By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 2/5 share of the total global market revenue by 2021-end.
Company Profiles:
Valeant Pharmaceuticals Inc.
Galderma S.A.
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Johnson & Johnson Services, Inc.
Bayer AG
Dr. Reddy's Laboratories Ltd.
Cipla Ltd.
Medimetriks Pharmaceuticals, Inc.
Others.
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/5840
The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2021-end.
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs.
However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for nearly 50% revenue share of the total dermatophytic onychomycosis therapeutics market by 2021-end, i.e. holding the maximum market share. Whereas Europe is projected to grow at a healthy CAGR due to increasing awareness about fungal nail infections.
Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/5840
All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights.
Access Related Reports-
Uveitis Treatment Market: https://www.persistencemarketresearch.com/market-research/uveitis-treatment-market.asp
Insomnia Treatment Market: https://www.persistencemarketresearch.com/market-research/insomnia-treatment-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Dermatophytic Onychomycosis Therapeutics Market to Witness Escalation Backed By Gene Therapies here
News-ID: 2553778 • Views: …
More Releases from Persistence Market Research

Global Warehouse Management Systems Market to Reach US$12.5 Bn by 2032
The global warehouse management systems (WMS) market is projected to grow from US$4.7 billion in 2025 to US$12.5 billion by 2032, registering a CAGR of 15.1%. The rapid growth of e-commerce, globalization of supply chains, and increasing demand for real-time inventory tracking are key drivers fueling this market. WMS software plays a critical role in streamlining warehouse operations, from receiving goods to shipping, ensuring accuracy, efficiency, and reduced operational costs.
North…

Global Home Security Systems Market to Reach US$ 76.9 Bn by 2032
The global home security systems market is projected to grow from US$47.6 billion in 2025 to US$76.9 billion by 2032, registering a CAGR of 7.2%. Increasing crime rates, rising property thefts, and growing urbanization are key factors driving demand for smarter and safer living environments. Both homeowners and businesses are seeking advanced security solutions that provide real-time monitoring, greater control, and enhanced protection against burglary, fire, and other threats.
North America…

Global Cargo Management Tech Market to Reach $11.4 Bn by 2032
The global cargo management technology solutions market is projected to grow from US$3.7 billion in 2025 to US$11.4 billion by 2032, registering a robust CAGR of 17.5%. The growth is fueled by the rapid expansion of e-commerce, increasing international trade, and rising demand for efficient logistics systems capable of handling large order volumes while ensuring timely deliveries. Businesses are increasingly seeking solutions that enhance operational efficiency, streamline supply chain processes,…

Digital Rights Management Market Trends and Growth Analysis 2025-2032
The global digital rights management (DRM) market is poised for significant growth, with its size expected to reach US$11.6 billion by 2032, up from US$5.5 billion in 2025, registering a robust CAGR of 11.2%. The increasing adoption of digital content across media, entertainment, and enterprise sectors has accelerated the demand for effective content protection solutions. As intellectual property rights become a focal point for businesses and consumers alike, the need…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…